ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 278

$702K Total Retail Price of All Prescriptions

Rank: 57 out of 278

295 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 295 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,211 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
AMLODIPINE BESYLATE 412 393 1 7
LEVOTHYROXINE SODIUM 411 383 2 2
FUROSEMIDE 391 384 3 6
CARVEDILOL 336 290 4 23
SIMVASTATIN 334 326 5 4
LISINOPRIL 297 268 6 5
OMEPRAZOLE 285 268 7 3
ATORVASTATIN CALCIUM 276 256 8 13
METOPROLOL SUCCINATE 206 197 9 10
METOPROLOL TARTRATE 179 162 10 9
ATENOLOL 178 169 11 18
DONEPEZIL HCL 177 177 12 29
HYDROCODONE-ACETAMINOPHEN 168 155 S3 13 1
POTASSIUM CHLORIDE 167 157 14 17
METFORMIN HCL ER 163 147 15 76
CRESTOR 159 154 16 19
LOSARTAN POTASSIUM 152 150 17 24
CLOPIDOGREL 138 134 18 20
PRAVASTATIN SODIUM 114 111 19 16
CITALOPRAM HBR 110 108 20 21
WARFARIN SODIUM 108 108 21 11
NEXIUM 107 107 22 14
TRAMADOL HCL 106 102 23 22
TAMSULOSIN HCL 104 94 24 32
FENOFIBRATE 99 92 25 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 83 26 31
TRAMADOL HCL-ACETAMINOPHEN 95 93 27 153
NAMENDA 94 94 28 48
LOSARTAN-HYDROCHLOROTHIAZIDE 94 94 28 54
GABAPENTIN 91 88 30 12
METFORMIN HCL 89 79 31 8
AZITHROMYCIN 88 84 32 39
LANTUS 88 87 32 56
POLYETHYLENE GLYCOL 3350 86 85 34 74
ZOLPIDEM TARTRATE 84 57 35 26
ALENDRONATE SODIUM 81 81 36 51
PLAVIX 79 79 37 30
PANTOPRAZOLE SODIUM 76 72 38 36
NIFEDIPINE ER 73 52 39 139
FELODIPINE ER 73 68 39 112
SPIRONOLACTONE 63 63 41 62
FLUTICASONE PROPIONATE 58 55 42 44
ALLOPURINOL 58 57 42 38
CEPHALEXIN 55 49 44 92
HYDROCHLOROTHIAZIDE 52 37 45 15
KLOR-CON M10 52 52 45 90
DIOVAN 52 52 45 43
VYTORIN 51 40 48 148
SERTRALINE HCL 50 46 49 25
PAROXETINE HCL 50 50 49 57
RANITIDINE HCL 50 50 49 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.